Barclays’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Buy |
58,082
+18,431
| +46% | +$124K | ﹤0.01% | 3167 |
|
|
2025
Q1 | $359K | Sell |
39,651
-11,714
| -23% | -$106K | ﹤0.01% | 3027 |
|
|
2024
Q4 | $887K | Buy |
51,365
+6,255
| +14% | +$108K | ﹤0.01% | 2702 |
|
|
2024
Q3 | $720K | Buy |
45,110
+30,585
| +211% | +$488K | ﹤0.01% | 2800 |
|
|
2024
Q2 | $208K | Sell |
14,525
-7,992
| -35% | -$114K | ﹤0.01% | 3028 |
|
|
2024
Q1 | $318K | Sell |
22,517
-9,213
| -29% | -$130K | ﹤0.01% | 3087 |
|
|
2023
Q4 | $479K | Buy |
31,730
+25,798
| +435% | +$389K | ﹤0.01% | 3023 |
|
|
2023
Q3 | $94K | Sell |
5,932
-508
| -8% | -$8.05K | ﹤0.01% | 3351 |
|
|
2023
Q2 | $97K | Sell |
6,440
-3,788
| -37% | -$57.1K | ﹤0.01% | 3415 |
|
|
2023
Q1 | $149K | Sell |
10,228
-544
| -5% | -$7.93K | ﹤0.01% | 3318 |
|
|
2022
Q4 | $146K | Buy |
10,772
+9,557
| +787% | +$130K | ﹤0.01% | 3259 |
|
|
2022
Q3 | $19K | Buy |
1,215
+1,179
| +3,275% | +$18.4K | ﹤0.01% | 3959 |
|
|
2022
Q2 | $0 | Sell |
36
-1,673
| -98% | – | ﹤0.01% | 4919 |
|
|
2022
Q1 | $16K | Buy |
+1,709
| New | +$16K | ﹤0.01% | 4392 |
|